Capital expenditure · 2011–2025
Ionis Pharmaceuticals capital expenditure
$51.4M+13.6% · FY2025
Ionis Pharmaceuticals (IONS) reported $51.4M in capital expenditure for fiscal 2025, +13.6% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $51.4M | +13.6% | Open → |
| FY20242024-12-31 | $45.3M | +90.2% | Open → |
| FY20232023-12-31 | $23.8M | +51.4% | Open → |
| FY20222022-12-31 | $15.7M | +31.5% | Open → |
| FY20212021-12-31 | $12.0M | −66.0% | Open → |
| FY20202020-12-31 | $35.1M | +13.6% | Open → |
| FY20192019-12-31 | $30.9M | +127.1% | Open → |
| FY20182018-12-31 | $13.6M | −60.9% | Open → |
| FY20172017-12-31 | $34.8M | +389.2% | Open → |
| FY20162016-12-31 | $7.1M | −7.6% | Open → |
| FY20152015-12-31 | $7.7M | +2.3% | Open → |
| FY20142014-12-31 | $7.5M | +384.4% | Open → |
| FY20132013-12-31 | $1.6M | +4.9% | Open → |
| FY20122012-12-31 | $1.5M | −85.5% | Open → |
| FY20112011-12-31 | $10.2M | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +12.2%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ionis Pharmaceuticals capital expenditure |url=https://companiesranked.com/en/company/ionis-pharmaceuticals/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ionis Pharmaceuticals capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/ionis-pharmaceuticals/capital-expenditureBibTeX
@misc{companiesranked-en-company-ionis-pharmaceuticals-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Ionis Pharmaceuticals capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ionis-pharmaceuticals/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000874015-26-000115 · February 26, 2026
{{cite web |title=Ionis Pharmaceuticals capital expenditure — 10-K (0000874015-26-000115) |url=https://www.sec.gov/Archives/edgar/data/874015/000087401526000115/form10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.